A newly published study from researchers at Lilly found greater weight loss with tirzepatide than semaglutide among adults treated for obesity in routine clinical practice. Published in the Journal of Endocrinological Investigation, the analysis examined outcomes...
Seizure frequency is one of the most important outcomes in epilepsy research, but it often lives in unstructured clinical notes rather than standard EHR fields. In a recent Neurology abstract, researchers from SK Life Science and Truveta show how the Truveta Language...
Respiratory virus-associated hospitalizations declined slightly in February 2026 to 3.6% of all hospitalizations. Among children aged 0-4 years, respiratory virus-associated hospitalizations increased slightly to 4.3% of all hospitalizations, with the increase driven...
Authors: Cheng Cao ⊕Truveta, Inc, Bellevue, WA, Jay Pillai ⊕Truveta, Inc, Bellevue, WA, Sara Daraei ⊕Truveta, Inc, Bellevue, WA, Sina Ghadermarzi ⊕Truveta, Inc, Bellevue, WA Key points Peer-reviewed paper, “Linking patient records at scale with a hybrid approach...
Substance use disorder (SUD) affects nearly 16.8% of Americans aged 12 and older, or more than 48 million people in the US. It is commonly seen in clinical practice, but rarely simple. In healthcare records, SUD does not always present as a single, stable diagnosis....
Older adults remain at highest risk for COVID-19–related hospitalization. Yet a new CDC analysis suggests that effective antiviral treatments are likely underprescribed among outpatients aged 65 or older, with prescribing patterns varying alongside disease...
